It’s has also been reported that miR-17-5p can directly target ETV resulting in suppressing cell proliferation and invasion in triple-negative breast cancer (12), while it can also enhance cell proliferation in pancreatic cancer by targeting RBL2/E2F4 (13). This evidence concerns the gene RBL2 and pancreatic neoplasm.